Asia-Pacific Americas Africa Europe Middle East

ELIXIR ILAC ARASTIRMA VE GELISTIRME

Company Profile:

Company Type: Factory (Manufacturer)

Company Introduction:

ELIXIR ILAC ARASTIRMA VE GELIŞTIRME A.Ş. is a pharmaceutical company based in Turkey. The company's name, which translates to "Medicine Research and Development," accurately reflects its primary focus. ELIXIR ILAC is dedicated to the research, development, and manufacturing of a diverse portfolio of pharmaceutical products. It specializes in developing innovative new drugs, biosimilars, and high-quality generic medications. The company also offers contract manufacturing services to other pharmaceutical enterprises, leveraging its advanced R&D laboratories and modern production facilities. ELIXIR ILAC is committed to upholding stringent international quality standards and regulatory compliance to contribute to global public health.

Enterprise Products

ELIXIR ILAC ARASTIRMA VE GELISTIRME is a pharmaceutical research and development company based in Turkey. Their primary focus is on developing drug formulations and providing related services to other pharmaceutical companies, rather than directly selling a wide range of branded products under their own name.

The types of pharmaceutical products they develop or are involved in include oncology products, immunology products, rheumatology products, ophthalmology products, products for rare diseases, biosimilars, biological products, high potency products, and orphan drugs. They offer services such as formulation development, analytical development, process development, and production of clinical trial materials for these product categories.

Business Registration Information:

Manager:

Dr. Emrah Kazan (General Manager)

Phone:

+90 216 504 04 20

E-mail:

info@elixirilac.com.tr

Official Website:
Address:

Teknopark İstanbul, Sanayi Mah. Teknopark Bulvarı No:1/1 A Blok Kat:3 No:310 Pendik / İstanbul / Türkiye

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.